Why One Blood Pressure Reading Can Mislead You, and the Truth About Vitamin D

A note from Dr. Goel

This week at Peak Human, the site added four new research write-ups and one supplement database update worth your attention: a hard look at how reliable a single blood pressure reading actually is, what a 25,871-person trial found on vitamin D, an honest read on polyphenol supplements, a deeper dive on Urolithin A's muscle-endurance evidence, and an updated record on methylated B-complex and brain health. As always — the research first, the hype never.

— Dr. Sanjeev Goel

🔬 This week's deep dive: How accurate is one blood pressure reading?

Most of us get diagnosed — or reassured — based on a single number, taken once, in a chair, with a cuff nobody checked the size of. New data added to the site this week suggests that number deserves far less trust than we give it.

What the research shows

Reading-to-reading variability: Across 444 patients and 111,181 ambulatory readings analyzed in the new post, no single clinic reading reliably indicated whether a patient's blood pressure was actually controlled.

Cuff size matters more than people assume: Using the wrong cuff size added as much as 19.5 mmHg of error in that analysis. Separately, a 2023 JAMA Internal Medicine crossover trial of 195 adults found that using a standard cuff on someone who needed a smaller or larger size was enough to shift their reading into a different hypertension category.

The honest caveats

This isn't an argument to ignore your blood pressure — it's an argument to stop trusting one number from one visit. Guidelines already call for averaging multiple readings, and out-of-office measurement exists precisely because a single clinic reading is a noisy instrument. If a diagnosis or a prescription was built on one reading, it's reasonable to ask for a repeat set, done with the correct cuff.

My take: Blood pressure is one of the most consequential numbers in medicine, and we routinely measure it like an afterthought. Before you accept a hypertension diagnosis — or relax because one reading looked fine — ask whether it was measured properly, more than once, with the correct cuff. This is exactly the kind of thing a real diagnostic workup catches and a rushed annual physical doesn't.

Want a blood pressure and cardiovascular workup done properly, instead of once, in passing?

Database update: methylated B-complex and brain aging

The supplement database's B-complex record now reflects the clearest trial evidence we have on B vitamins and brain atrophy.

VITACOG trial: In a randomized, placebo-controlled trial of 271 adults over 70 with mild cognitive impairment, high-dose folic acid, B12 and B6 slowed the rate of brain atrophy by roughly 30% overall — and by around 53% in the subgroup that started with elevated homocysteine levels.

New on the blog: supplement or sunlight for vitamin D?

Vitamin D is one of the best-selling supplements on earth. Two of the largest trials ever run on it tell a more complicated story than the marketing.

VITAL trial: In a placebo-controlled trial of 25,871 U.S. adults given 2,000 IU/day of vitamin D3 for a median of 5.3 years, supplementation did not significantly reduce invasive cancer incidence (HR 0.96) or major cardiovascular events (HR 0.97) versus placebo.

Why the null result may not be the whole story: Most participants in these large trials were already vitamin D–replete at baseline — any benefit looks concentrated in people who start out deficient, not in everyone.

New on the blog: do polyphenol supplements work?

Resveratrol, pomegranate extract, cocoa flavanols — polyphenol supplements carry a lot of promise and a thinner evidence base than most people assume.

A mixed signal in a small trial: In 78 postmenopausal women, a concentrated pomegranate/resveratrol/red clover blend raised LDL cholesterol by about 9.5% while cutting oxidized LDL by about 39% — a trade-off, not a clean win.

The largest trial disagreed: COSMOS, the largest cocoa-flavanol trial ever run (n=21,442), missed its primary cardiovascular endpoint.

New on the blog: does Urolithin A actually work?

We expanded last week's database update into a full write-up, because the underlying meta-analysis deserved more room than a database record gives it.

The pooled number: Across 5 randomized trials (n=236), the pooled effect on 6-minute walk distance was a modest +17 meters — but the confidence interval crosses zero, and a correction for small-study bias cut the estimate by roughly 38%.

Curious what a physician-vetted, evidence-first supplement stack looks like once this kind of research gets applied?

📰 Longevity news worth your minute

Longevity's calendar is full this month. The Asia-Pacific Healthy Longevity International Summit drew more than 1,000 clinicians, researchers and investors to Hong Kong in early October, alongside the Top 10 Longevity Breakthrough Awards spanning diagnostics, AI-assisted screening and regenerative medicine.

Aging research is drawing more regulatory attention. This month's Aging Research and Drug Discovery meeting in Boston reportedly saw growing involvement from regulators, including senior U.S. government representation — a sign aging itself is being taken more seriously as a treatable target.

⚕️ Important disclaimer

This newsletter is for educational purposes only and is not medical advice. Compounds discussed may be investigational and not FDA-approved. Nothing here is a recommendation to start, stop, or change any treatment. Peptide and metabolic therapies carry real risks and should only be used under qualified medical supervision. Always consult your physician before making health decisions.